NEAT1 and metabolic dysfunction-associated steatotic liver disease: In the present review, NEAT1 expression levels were found to be upregulated in serum and PBMCs of NAFLD patients, and it was also upregulated in both NAFLD-related inflammation and advanced fibrosis, which was consistent with previous studies conducted in vitro and in vivo.